Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ·Healthcare·Biotechnology
$3.64
-4.21%
Mkt Cap $11.42M
No analyst coverage available
We don't have analyst ratings or price target data for Lixte Biotechnology Holdings, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.